Cite
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.
MLA
Rossmeisl, John H., et al. “Phase I Trial of Convection-Enhanced Delivery of IL13RA2 and EPHA2 Receptor Targeted Cytotoxins in Dogs with Spontaneous Intracranial Gliomas.” Neuro-Oncology, vol. 23, no. 3, Mar. 2021, pp. 422–34. EBSCOhost, https://doi.org/10.1093/neuonc/noaa196.
APA
Rossmeisl, J. H., Herpai, D., Quigley, M., Cecere, T. E., Robertson, J. L., D’Agostino, R. B., Hinckley, J., Tatter, S. B., Dickinson, P. J., & Debinski, W. (2021). Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas. Neuro-Oncology, 23(3), 422–434. https://doi.org/10.1093/neuonc/noaa196
Chicago
Rossmeisl, John H, Denise Herpai, Mindy Quigley, Thomas E Cecere, John L Robertson, Ralph B D’Agostino, Jonathan Hinckley, Stephen B Tatter, Peter J Dickinson, and Waldemar Debinski. 2021. “Phase I Trial of Convection-Enhanced Delivery of IL13RA2 and EPHA2 Receptor Targeted Cytotoxins in Dogs with Spontaneous Intracranial Gliomas.” Neuro-Oncology 23 (3): 422–34. doi:10.1093/neuonc/noaa196.